Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Gallbladder Neoplasms × Radiofrequency Ablation × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 10 Liver Neoplasms 5 Colorectal Neoplasms 3 Cholangiocarcinoma 3 Thyroid Diseases 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Thyroid Nodule 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Solid Tumor Including Thyroid, Bone, Liver, Pancreas 1 Papillary Thyroid Microcarcinoma 1 Neoplasms, Glandular and Epithelial 1 Neoplasms 1 NSCLC 1 Lung Neoplasms 1 Hypertension, Portal 1 Hyperaldosteronism 1 Hepatic Metastasis of Colorectal Cancer 1 HCC 1 Gallbladder Neoplasms 1 Colorectal Cancer Liver Metastases 1 Colonic Neoplasms 1 Cholestasis 1 Carcinoma, Non-Small-Cell Lung 1 Cancer Pain 1 Breast Neoplasms 1 Bile Duct Neoplasms 1 Barrett Esophagus 1 Agnosia 1

Interventions

Gemcitabine 4 Oxaliplatin 3 Fluorouracil 3 Capecitabine 3 Leucovorin 2 Irinotecan 2 toripalimab 1 tislelizumab 1 taxane 1 surufatinib 1 lenvatinib 1 Urination 1 Trastuzumab 1 Tomography, X-Ray Computed 1 Temozolomide 1 Tegafur 1 Taxes 1 Stents 1 Sorafenib 1 S 1 (combination) 1 Radiotherapy 1 Radiofrequency Ablation 1 Polymerase Chain Reaction 1 Platinum Compounds 1 Observation 1 Mutation 1 Minimally Invasive Surgical Procedures 1 Microbiota 1 Methylation 1 Mass Spectrometry 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05320328 2022-04-11

MBOP

Asian Institute of Gastroenterology, India

Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡